GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended March 31, 2025. The Notice can be accessed at the Company''s Website at www.gkb.net Further,notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulation, 2015, had been closed from April 01, 2025, will now re-open after the completion of 48 hours from the date of submission of financials results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.